Skip to content
Search

Latest Stories

RPS launches new programme to enhance pharmacists' prescribing skills

RPS launches new programme to enhance pharmacists' prescribing skills

It aims to equip pharmacists with the essential knowledge, skills, and confidence to diagnose and treat common conditions and minor ailments

The Royal Pharmaceutical Society (RPS) has introduced a new comprehensive learning programme to support pharmacists in Wales to deliver the Pharmacy Independent Prescribing Service (PIPS).


Developed in collaboration with Health Education and Improvement Wales (HEIW), the programme is designed to “equip pharmacists with the essential knowledge, skills, and confidence needed to provide excellent patient care.”

While the primary emphasis is on pharmacists operating within primary care settings, those from various practice settings are also encouraged to register and participate in the programme.

Commenting on the collaboration with HEIW, Elen Jones, director for Wales at the Royal Pharmaceutical Society, said that it will empower pharmacists across the country to deliver high-quality prescribing services to local communities.

“By equipping pharmacists with the knowledge, skills, and confidence to treat specific conditions as prescribers, we are not only enhancing the quality of patient care but also strengthening the role of pharmacists as vital members of the healthcare team,” she added.

The programme has been designed by pharmacists from the RPS education and professional development team, with the content for each session being written by practising pharmacist prescribers or general practitioners.

Each session will explore conditions commonly encountered in community pharmacy practice.

Acknowledging the contribution of prescribing pharmacists in Wales, Jones said: “Through collaboration with Community Pharmacy Wales, feedback was obtained which has ensured its relevance and effectiveness in meeting the professional development needs of pharmacists,” Jones said.

“The programme's focus on common conditions and minor ailments aligns perfectly with the everyday challenges faced by pharmacists in their practice,” she added.

Margaret Allan, Pharmacy Dean at Health Education and Improvement Wales, reiterated HEIW’s commitment to developing education and training for the pharmacy workforce, aligning with the objectives of Pharmacy: Delivering a Healthier Wales.

“Through our collaboration with the RPS on this series of events for pharmacist independent prescribers, we hope to improve confidence in prescribing and equity of access to the provision of the PIPS across Wales,” Allan said.

Key features of the programme

Under this programme, participants will learn to diagnose common conditions and minor ailments, identify red flag symptoms, know when and how to refer patients to other healthcare services, and treat common conditions and minor ailments.

The sessions will be presented as six separate two-hour workshops, incorporating presentations, knowledge quizzes, group activities, case study discussions, and Q&A sessions with experts.

The in-person workshops will be organised across North Wales, Mid and West Wales, and South Wales.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less